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Background. Plasmodium falciparum may evade complement-mediated host defense by hijacking complement Factor H (FH), a 
negative regulator of the alternative complement pathway. Plasma levels of FH vary between individuals and may therefore influence 
malaria susceptibility and severity.
Methods. We measured convalescent FH plasma levels in 149 Gambian children who had recovered from uncomplicated or 
severe P. falciparum malaria and in 173 healthy control children. We compared FH plasma levels between children with malaria 
and healthy controls, and between children with severe (n = 82) and uncomplicated malaria (n = 67). We determined associations 
between FH plasma levels and laboratory features of severity and used multivariate analyses to examine associations with FH when 
accounting for other determinants of severity.
Results. FH plasma levels differed significantly between controls, uncomplicated malaria cases, and severe malaria cases 
(mean [95% confidence interval], 257 [250 to 264], 288 [268 to 309], and 328 [313 to 344] µg/mL, respectively; analysis of variance 
P < .0001). FH plasma levels correlated with severity biomarkers, including lactate, parasitemia, and parasite density, but did not cor-
relate with levels of PfHRP2, which represent the total body parasite load. Associations with severity and lactate remained significant 
when adjusting for age and parasite load.
Conclusions. Natural variation in FH plasma levels is associated with malaria susceptibility and severity. A prospective study 
will be needed to strengthen evidence for causation, but our findings suggest that interfering with FH binding by P. falciparum might 
be useful for malaria prevention or treatment.
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Malaria accounts for a huge global burden of disease. Plasmodium 
falciparum infections account for most of this burden, and most 
attributable deaths occur in young children in sub-Saharan 
Africa. Three clinical syndromes of severe malaria, occurring 
alone or in combination, predict the majority of deaths in chil-
dren: cerebral malaria (characterized by coma), severe anemia, 
and respiratory distress (which usually indicates metabolic 
acidosis and hyperlactatemia) [1]. Why some children develop 
severe malaria and others do not is poorly understood.
The complement system is activated as part of the innate 
immune response to malaria [2]. P. falciparum is vulnerable to 
complement-mediated defenses when parasites exit host cells 
to invade new erythrocytes or undergo sexual reproduction 
[2]. Rapid activation of complement opsonizes invading para-
sites for phagocytosis or lyses them directly and stimulates the 
adaptive immune response. Although complement activation 
is likely to be protective, excessive activation would be detri-
mental to the host, contributing to dysregulated inflammation 
and destruction of uninfected erythrocytes [2]. To prevent 
bystander damage, the complement system is tightly regu-
lated by various fluid phase and membrane-bound regulators. 
One important regulator protecting host endothelial cells and 
erythrocytes is the alternative pathway inhibitor factor H (FH), 
which normally circulates in the blood at ~300 µg/mL [3].
FH plays an essential role in regulating complement activ-
ity, and its genetic deficiency results in atypical hemolytic ure-
mic syndrome [3]. However, many microbes have evolved to 
hijack FH to minimize complement activation on their outer 
membranes. A well-characterized example is Neisseria menin-
gitidis, for which high FH plasma levels increase susceptibility 
to invasive disease [4, 5]. P. falciparum can also recruit FH to its 
surface, protecting parasites from complement and raising the 
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possibility that variation in plasma levels of FH may also influ-
ence outcomes in malaria [6–9].
Although in vitro studies on the mechanisms of FH binding 
to the malaria parasite demonstrate a plausible mechanism of 
evading host defense, clinical studies are needed to determine 
the relevance to disease outcomes. As it has previously been 
shown that complement activation levels return to normal 
within a month after a malaria episode [10], we determined 
convalescent FH plasma levels of children who required hos-
pital treatment for P.  falciparum malaria as a proxy for the 
steady-state situation preceding infection. We compared levels 
with healthy community controls and between those who had 
suffered uncomplicated vs severe malaria.
METHODS
Patients and Samples
Subjects were Gambian children (<16  years old) recruited 
from the Greater Banjul region, where malaria transmission 
is seasonal and relatively low [11]. Convalescent heparinized 
plasma was obtained 28  days after presentation from chil-
dren (median age [interquartile range {IQR}], 5 [3–8] years) 
who had received hospital treatment for P. falciparum malaria 
with a parasite density >5000/µL [12–14]. Severe malaria was 
classified by the presence of 1 or more of the following: severe 
anemia (SA; hemoglobin < 5 g/dL), hyperlactatemia (LA; lac-
tate > 5 mM), cerebral malaria (CM; Blantyre Coma Scale < 3), 
or prostration (SP) [14]. Samples were collected from healthy 
community control children of similar age (median age [IQR], 
3.9 [2.4–5.5] years), recruited from the same region between 
2013 and 2014. Control children were not tested for asymp-
tomatic parasitemia. The study was approved by the Gambia 
Government/UK Medical Research Council Joint Ethics 
Committee and performed in accordance with the Declaration 
of Helsinki.
Factor H and P. falciparum Histidine Rich Protein 2 (PfHRP2) Emzyme-
Linked Immunosorbent Assay
Enzyme-linked immunosorbent assays (ELISAs) to meas-
ure Factor H and PfHRP2 were performed as previously 
described [14, 15].
Statistics
Analysis was performed with GraphPad Prism v7.02 (GraphPad 
Software, La Jolla, CA, USA). Differences in mean values 
between groups were assessed by unpaired t test or 1-way 
analysis of variance (ANOVA) with Tukey’s multiple compar-
isons test. Correlations were assessed using a nonparamet-
ric Spearman’s correlation test. Logistic and linear regression 
models were developed using the GLM function in R. The best 
model was assessed by the Akaike Information Criterion.
RESULTS
To determine whether FH levels may associate with malaria 
susceptibility and severity, we measured FH in convalescent 
samples from children with uncomplicated (n = 67) and severe 
(n = 82) malaria and in healthy community controls (n = 173). 
Because severe malaria is more common in younger children 
we first tested whether FH levels were associated with age and 
found that they were not significantly correlated (n  =  322, 
rs = –.034, P = .54), as was expected based on a previous study 
in healthy children [16].
We then tested whether FH levels were different between 
healthy controls and malaria cases. FH levels were lowest in 
healthy controls, intermediate in convalescent uncomplicated 
malaria cases, and highest in convalescent severe malaria cases 
(mean [95% confidence interval {CI}], 257 [250 to  264], 288 
[268 to 309], and 328 [313 to 344] µg/mL, respectively; ANOVA 
P  <  .0001) (Figure  1A). This indicates that both the need for 
hospital treatment for malaria and severity of malaria associate 
with FH.
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Figure 1. Factor H (FH) plasma levels associate with malaria susceptibility and severity. A, FH was measured by in-house enzyme-linked immunosorbent assay in samples 
from healthy community control children (HC; n = 173) and in samples obtained 28 days after hospital presentation from children with uncomplicated malaria (UM; n = 67) 
and severe malaria (SM; n = 82). P values indicate Tukey’s multiple comparisons test performed after 1-way analysis of variance. B, Severe malaria was categorized based 
on major criteria of severity: severe prostration (SP; n = 69), hyperlactatemia (LA; n = 48), severe anemia (SA; n = 14), and cerebral malaria (CM; n = 29). Due to overlapping 
clinical features, depicted groups are not mutually exclusive. Unpaired t tests compare the mean of each group with uncomplicated malaria. Bars indicate mean ± SD.
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Severe malaria can manifest in several overlapping syn-
dromes; therefore, we examined whether the higher levels of 
FH in those with severe malaria were driven by any particular 
clinical phenotype. FH levels were similar in all major severe 
malaria phenotypes and were all significantly higher than in 
uncomplicated malaria, with the exception of the small group 
with SA (mean difference [95% CI] compared with uncom-
plicated malaria: SP, 43 [18 to 69] µg/mL; LA, 43 [13 to 73] 
µg/mL; SA,  41 [–8 to  90] µg/mL; CM,  37 [2 to  71] µg/mL) 
(Figure 1B).
To further investigate the association between FH and sever-
ity, we assessed relationships between convalescent FH and 
several host- and parasite-derived markers measured on admis-
sion. Lactate concentrations correlated significantly with FH 
levels, but platelets and hemoglobin did not (Figure  2A–C). 
Markers of circulating parasite load, parasitemia assessed from 
blood film and parasites/µL, showed significant positive corre-
lations with FH levels (Figure 2D, E).
Measures of circulating parasite load do not quantify add-
itional cyto-adherent parasites sequestered in the tissue 
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Figure 2. Factor H (FH) plasma levels associate with severity markers. A–D, Correlations of FH plasma levels with severity markers at the time of presentation to hospital: 
(A) lactate, (B) platelets, (C) hemoglobin (Hb), (D) parasitemia (% of infected erythrocytes in blood film), (E) parasite density, (F) PfHRP2, (G) sequestration index [log (PfHRP2/
parasitemia)]. Spearman’s correlations.
D
ow
nloaded from
 https://academ
ic.oup.com
/ofid/article-abstract/5/7/ofy166/5056423 by London School of H
ygiene & Tropical M
edicine user on 20 Septem
ber 2018
4 • OFID • van Beek et al
microvasculature. Total body parasite load can be assessed 
using the plasma concentration of the soluble parasite pro-
tein PfHRP2, which reflects both sequestered and circulating 
parasite numbers and is more predictive of clinical outcome 
of infection [14, 17]. Surprisingly, there was no correlation 
between PfHRP2 concentration and FH (Figure  2F). As an 
index of sequestration, we calculated the ratio of PfHRP2 to 
parasitemia (higher values would be expected to indicate rel-
atively more sequestration) and found that this was negatively 
correlated with FH (Figure 2G).
In logistic regression models, age, PfHRP2, and FH all pre-
dicted severity, and a multivariate model incorporating all 3 
indicated that that they have independent associations with 
outcome (Table  1). Linear regression models indicated that 
age, PfHRP2, and FH were also independently associated with 
blood lactate concentration (Table 2).
DISCUSSION
Despite the huge evolutionary pressure malaria has exerted, 
surprisingly few host factors have been convincingly shown 
to influence susceptibility or severity. Of the host factors with 
the strongest evidence, almost all involve the erythrocyte [18]. 
Our results suggest that natural variation in FH levels is another 
determinant of malaria susceptibility and severity.
All children in malaria-endemic countries are potentially 
susceptible to P. falciparum infection, but not all of these infec-
tions will result in symptomatic malaria. The likelihood of an 
infection causing symptomatic disease is dependent on para-
site density [19]. As we only included children seeking hospital 
treatment with >5000 parasites/µL in our study, we ensured 
high specificity of the malaria diagnosis.
By comparing healthy children with those who had suffered a 
definite malaria episode, we expected that even relatively small 
differences in FH between the groups would indicate an asso-
ciation between FH and susceptibility to symptomatic malaria: 
the outcome of a new infection in the controls could be either 
asymptomatic or symptomatic, whereas our malaria cases are 
all symptomatic. Thus our results indicate that higher levels of 
FH are associated with susceptibility to symptomatic malaria. 
Among subjects with malaria, the associations of FH with clin-
ical features of severe disease, lactate concentration and cir-
culating parasite load, are consistent with the hypothesis that 
higher levels of FH also predispose to severe malaria. Indeed, 
multivariate models suggested that the association of FH with 
severity was independent of both age and parasite load.
Although high FH levels may allow parasites to evade 
complement-mediated clearance, high levels may also limit 
endothelial activation and expression of adhesion molecules 
involved in sequestration of parasitized erythrocytes [2]. If high 
FH levels favor parasite multiplication but restrict sequestra-
tion, one might expect a stronger correlation with circulating 
parasite load than with PfHRP2 concentration (which reflects 
both circulating and sequestered parasites). This would also be 
consistent with the negative correlation observed between FH 
and the sequestration index (PfHRP2:parasitemia).
Although total body parasite load is a strong predictor of 
severity, it is not the only determinant [20]. The rapidity of par-
asite growth in the circulation may also contribute to severity if 
Table 1. Logistic Regression Models to Predict Severity
Model Variable No. Log Odds SE P AIC
Age Age 149 –0.37 0.069 5.3 × 10-8 165
Log PfHRP2 Log PfHRP2 104 1.06 0.25 2.2 × 10-5 127
FH FH 149 0.0066 0.0023 .0047 205
Age + log PfHRP2 + FH Age 104 –0.45 0.11 2.68 × 10-5 87
Log PfHRP2 0.91 0.27 .00098
FH 0.01 0.0045 .00133
Age, PfHRP2, and FH were assessed individually or combined in a multivariate model to predict severity.
Abbreviations: AIC, Akaike Information Criterion; FH, Factor H.
Table 2. Linear Regression Model to Predict Blood Lactate Concentration
Model Variable No. Coefficient SE P AIC
Age Age 138 –0.11 0.015 3.02 × 10-11 263
Log PfHRP2 Log PfHRP2 100 0.23 0.036 6.7 × 10-9 166
FH FH 138 0.002 0.00077 .0094 301
Age + log PfHRP2 + FH Age 100 –0.073 0.012 7.4 × 10-8 131
Log PfHRP2 0.18 0.030 3.5 × 10-8
FH 0.0021 0.00063 .0011
Age, PfHRP2, and FH were assessed individually or combined in a multivariate model to predict ln (lactate).
Abbreviations: AIC, Akaike Information Criterion; FH, Factor H.
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the consequent pro-inflammatory responses occur faster than 
regulatory and protective responses, which are necessary to 
limit immunopathology. Our study design precluded analysis 
of nonsurvivors, so we cannot exclude the possibility that high 
FH levels modulated the risk of death.
The main limitation of our study is that we used convales-
cent plasma samples, which we believe are representative of the 
pre-infection status of our subjects. We cannot exclude that dif-
ferences in FH levels could represent a residual effect of infec-
tion, although we think this is unlikely because of the lack of 
association with PfHRP2 concentrations. A  large prospective 
study would be required to confirm that natural variation in 
FH levels definitely does predict susceptibility, severity, and 
mortality from malaria. Further studies will be needed to clar-
ify the relative roles of complement activation and regulation 
in malaria, but interference with parasite FH binding might be 
considered as an adjunctive approach to limit parasite growth, 
enhance parasite clearance, and tackle drug resistance.
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